<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-metoprolol.xml</id>
  <title>Recalls Watch: Metoprolol</title>
  <link rel="self" href="https://recalls.watch/feed/substance-metoprolol.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-11-11T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/100234/</id>
    <title>Advagen Pharma Limited: Metoprolol Tartrate Tablets</title>
    <link href="https://recalls.watch/recall/fda/100234/"/>
    <updated>2026-11-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablets/Capsules</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98821/</id>
    <title>Ascend Laboratories, LLC: Ascend Laboratories</title>
    <link href="https://recalls.watch/recall/fda/98821/"/>
    <updated>2026-05-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98348/</id>
    <title>Teva Pharmaceuticals USA, Inc: Metoprolol Succinate Extended-Release Tablets and 3 more</title>
    <link href="https://recalls.watch/recall/fda/98348/"/>
    <updated>2026-03-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97395/</id>
    <title>Westminster Pharmaceuticals LLC: Metoprolol Tartrate Tablets and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97395/"/>
    <updated>2025-08-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97131/</id>
    <title>Granules Pharmaceuticals Inc.: Metoprolol Succinate Extended-Release Tablets</title>
    <link href="https://recalls.watch/recall/fda/97131/"/>
    <updated>2025-07-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94542/</id>
    <title>Rubicon Research Private Limited: Metoprolol Tartrate Tablets USP</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94542"/>
    <updated>2024-06-05T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Substance: metal in tablet</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/89450/</id>
    <title>CARDINAL HEALTHCARE: Ipratropium Bromide and Albuterol Sulfate Inhalation Solution and 41 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=89450"/>
    <updated>2024-01-03T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.</summary>
  </entry>
</feed>
